Annick Cauvin

Annick Cauvin is a Senior Director of Non-Clinical Safety Evaluation at UCB Biopharma SPRL since April 2023, with an extensive career at UCB Pharma that began in April 2008, where roles included Director and Associate Director of Non-Clinical Safety Evaluation, focusing on non-clinical safety for new biological entities and new chemical entities. Prior experience includes a Project Leader position at Themis Holding from January 2007 to March 2008, management of R&D projects as a consultant toxicologist at Unibioscreen S.A. in 2007-2008, and a Principal Research Scientist at Eli Lilly & Company from September 1992 to December 2006. Earlier in the career, Annick Cauvin worked as a Research Scientist at Hybritech. Annick Cauvin holds a PhD in Applied Medical Biology from Université libre de Bruxelles, obtained between 1982 and 1989.